Cargando…
Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We descr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964689/ https://www.ncbi.nlm.nih.gov/pubmed/27512301 http://dx.doi.org/10.4103/0971-4065.168143 |